Serge L. Boulet

Synthesis and Pharmacological Characterization of 2-(2,6-Dichlorophenyl)-1-((1<i>S</i>,3<i>R</i>)-5-(3-hydroxy-3-methylbutyl)-3-(hydroxymethyl)-1-methyl-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)ethan-1-one (LY3154207), a Potent, Subtype Selective, and Orally Available Positive Allosteric Modulator of the Human Dopamine D1 Receptor

Junliang Hao, James P. Beck, John M. Schaus et al. · Journal of Medicinal Chemistry · 2019 · 56 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Abstract 1259: Preclinical characterization of LY3537982, a novel, highly selective and potent KRAS-G12C inhibitor

Sheng-Bin Peng, Chong Si, Youyan Zhang et al. · Cancer Research · 2021 · 45 citations

Medicine, Oncology, Pharmacology +15

Toward a Total Synthesis of Okilactomycin. 2. A Metathesis-Based Approach to the Heavily Functionalized Cyclohexane Ring

Serge L. Boulet, Leo A. Paquette · Synthesis · 2002 · 30 citations

Natural Sciences, Chemistry, Medicinal Chemistry +17

Total syntheses of the diterpenoids (±)-verrucosan-2β-ol, (±)-neoverrucosan-5β-ol, and (±)-homoverrucosan-5β-ol. An approach to the synthesis of the sesterterpenoid variecolin

Edward Piers, Serge L. Boulet · Tetrahedron Letters · 1997 · 25 citations

Natural Sciences, Chemistry, Medicinal Chemistry +13

Toward a Total Synthesis of Okilactomycin. 1. A Direct, Enantiocontrolled Route to the Western Sector

Leo A. Paquette, Serge L. Boulet · Synthesis · 2002 · 25 citations

Natural Sciences, Chemistry, Medicinal Chemistry +17